p53 as a prognostic and predictive factor in early stage breast cancer, has had mixed results. We studied p53 protein expression, by immunohistochemistry, in a randomized clinical trial of stage II patients treated with adjuvant doxorubicin and cyclophosphamide with or without paclitaxel (CALGB 9344, INT0148)
Aims The utility of p53 as a prognostic assay has been elusive. The aims of this study were to descr...
Pre-clinical data suggest p53-dependent anthracycline-induced apoptosis and p53-independent taxane a...
We hypothesized that the functional status of p53 transcriptional pathways, rather than p53 protein ...
p53 as a prognostic and predictive factor in early stage breast cancer, has had mixed results. We st...
Introduction and aims: The p53 protein is a mediator of the cellular response to DNA damage. The aim...
Breast cancer is an increasingly important cause of illness and death among women. In recent years s...
Introduction and Aims: p53 protein is a mediator of the cellular response to DNA damage. Mutation in...
The most important subgroup of breast cancer patients for which reliable prognostic factors are need...
INTRODUCTION AND AIMS: The p53 protein is a mediator of the cellular response to DNA damage. The a...
INTRODUCTION: Pre-clinical data suggest p53-dependent anthracycline-induced apoptosis and p53-indepe...
INTRODUCTION: Pre-clinical data suggest p53-dependent anthracycline-induced apoptosis and p53-indepe...
P53; a tumor suppressor gene has known to have a role in a group of human cancers. Its role in breas...
Most studies are in favor of a prognostic relevance of p53 accumulation determined by immunohistoche...
Aims The utility of p53 as a prognostic assay has been elusive. The aims of this study were to descr...
Pre-clinical data suggest p53-dependent anthracycline-induced apoptosis and p53-independent taxane a...
We hypothesized that the functional status of p53 transcriptional pathways, rather than p53 protein ...
p53 as a prognostic and predictive factor in early stage breast cancer, has had mixed results. We st...
Introduction and aims: The p53 protein is a mediator of the cellular response to DNA damage. The aim...
Breast cancer is an increasingly important cause of illness and death among women. In recent years s...
Introduction and Aims: p53 protein is a mediator of the cellular response to DNA damage. Mutation in...
The most important subgroup of breast cancer patients for which reliable prognostic factors are need...
INTRODUCTION AND AIMS: The p53 protein is a mediator of the cellular response to DNA damage. The a...
INTRODUCTION: Pre-clinical data suggest p53-dependent anthracycline-induced apoptosis and p53-indepe...
INTRODUCTION: Pre-clinical data suggest p53-dependent anthracycline-induced apoptosis and p53-indepe...
P53; a tumor suppressor gene has known to have a role in a group of human cancers. Its role in breas...
Most studies are in favor of a prognostic relevance of p53 accumulation determined by immunohistoche...
Aims The utility of p53 as a prognostic assay has been elusive. The aims of this study were to descr...
Pre-clinical data suggest p53-dependent anthracycline-induced apoptosis and p53-independent taxane a...
We hypothesized that the functional status of p53 transcriptional pathways, rather than p53 protein ...